These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3531024)

  • 1. Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli.
    Hof H; Christen A; Hacker J
    Infection; 1986; 14(4):190-4. PubMed ID: 3531024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model.
    Wang L; Tkhilaishvili T; Bernal Andres B; Trampuz A; Gonzalez Moreno M
    Int J Antimicrob Agents; 2020 Dec; 56(6):106200. PubMed ID: 33075514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin and co-trimoxazole in urinary tract infection.
    Williams AH; Grüneberg RN
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():107-10. PubMed ID: 3492487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentin (amoxycillin-clavulanic acid) compared with co-trimoxazole in urinary tract infections.
    Fancourt GJ; Matts SG; Mitchell CJ
    Br Med J (Clin Res Ed); 1984 Jul; 289(6437):82-3. PubMed ID: 6428687
    [No Abstract]   [Full Text] [Related]  

  • 5. [Present status of the treatment of urological infections].
    Ukhin AV
    Antibiot Med Biotekhnol; 1985 May; 30(5):384-91. PubMed ID: 3896135
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women.
    Henry NK; Schultz HJ; Grubbs NC; Muller SM; Ilstrup DM; Wilson WR
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():103-6. PubMed ID: 3492486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [One time therapy of urinary tract infections with amoxicillin or co-trimoxazole. A randomized study].
    Wetzel H; Stille W
    Med Welt; 1981 Nov; 32(46):1753-6. PubMed ID: 6975870
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of Augmentin and co-trimoxazole in the treatment of adult infections in general practice.
    Davies JG; Rose AJ; Walker GD
    Br J Clin Pract; 1982 Dec; 36(11-12):387-93, 403. PubMed ID: 6984654
    [No Abstract]   [Full Text] [Related]  

  • 9. Further data on augmentin and co-trimoxazole in the treatment of urinary tract infection.
    Matts SG; Fancourt GJ; Mitchell CJ; Gowers E; Boston PF
    Br J Clin Pract; 1985 May; 39(5):179-84. PubMed ID: 3907682
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin.
    Brumfitt W; Hamilton-Miller JM
    Br J Clin Pract; 1985 Sep; 39(9):346-51. PubMed ID: 3904797
    [No Abstract]   [Full Text] [Related]  

  • 11. Current problems in antimicrobial therapy for bacterial enteric infection.
    DuPont HL; Ericsson CD; Robinson A; Johnson PC
    Am J Med; 1987 Apr; 82(4A):324-8. PubMed ID: 3555056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of urinary tract infection with a single dose of amoxycillin, co-trimoxazole, or trimethoprim.
    Harbord RB; Grüneberg RN
    Br Med J (Clin Res Ed); 1981 Nov; 283(6302):1301-2. PubMed ID: 6794831
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative Activity of Ceftriaxone, Ciprofloxacin, and Gentamicin as a Function of Bacterial Growth Rate Probed by Escherichia coli Chromosome Replication in the Mouse Peritonitis Model.
    Haugan MS; Løbner-Olesen A; Frimodt-Møller N
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative trial of amoxycillin and co-trimoxazole in the treatment of urinary-tract infection.
    Grob PR; Beynon GP; Gibbs FJ; Manners BT
    Practitioner; 1977 Aug; 219(1310):258-63. PubMed ID: 331295
    [No Abstract]   [Full Text] [Related]  

  • 15. Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.
    Rylander M; Norrby SR; Svärd R
    Scand J Infect Dis; 1987; 19(5):551-7. PubMed ID: 3321412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
    Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
    J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
    Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
    J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of chloramphenicol, co-trimoxazole (trimethoprim/sulphamethoxazole), cefmenoxime and ceftriaxone in experimental bacteraemia and meningitis caused by ampicillin-resistant Haemophilus influenzae type b.
    Kim KS
    J Antimicrob Chemother; 1988 Nov; 22(5):697-706. PubMed ID: 3264831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of Salmonella enteric fever.
    Limson BM; Littaua RT
    Infection; 1989; 17(2):105-6. PubMed ID: 2785506
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
    O'Halloran C; Walsh N; O'Grady MC; Barry L; Hooton C; Corcoran GD; Lucey B
    Br J Biomed Sci; 2018 Jan; 75(1):24-29. PubMed ID: 29210602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.